Markel Group Inc. MKL ← Back to all reports

Markel Group Inc.

MKL · Financials
A ★★★★ Buy
Jul 16, 2026 · Score 85 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $1,949.75
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $1,890.00 ($1,840.86–$1,940.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $2,250.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+15.4%

Type A - Markel Group Inc. (MKL) 20260716 Stock Analysis

📅 Markel Group Key Upcoming Events

🏢 Step 1: Markel Group Company Overview & Business Model

Q1-A1. What is Markel Group?

Q1-A2. How Does Markel Group Make Money?

Q1-A3. Markel Group’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Markel Group’s Competitors?

Q1-A5. Markel Group Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Markel Group’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Markel Group Have a Durable Economic Moat?

Q2-A2. Is Markel Group’s Growth Sustainable?

Q2-A3. How Does Markel Group Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Markel Group Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Markel Group? (Margins & ROIC)

Q3-A3. What Drives Markel Group’s Returns? (ROIC Breakdown)

Q3-A4. Are Markel Group’s Earnings High Quality?

Q3-A5. Is Markel Group’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Markel Group Forensic Accounting & Dilution Review

Q4-A1. Does Markel Group Have Accounting Red Flags?

Q4-A2. Is Markel Group Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Markel Group’s Cash Flow?

Q4-A4. Is Markel Group Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Markel Group Management & Shareholder Alignment

Q5-A1. Can You Trust Markel Group’s Management? (Guidance Track Record)

Q5-A2. What Are Markel Group Insiders Doing?

Q5-A3. Is Markel Group’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Markel Group Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Markel Group Guidance

Q6-A2. What Is Markel Group’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Markel Group Catalysts & Price Triggers

Q7-A1. What Could Move Markel Group Stock? (Top 3 Catalysts)

Q7-A2. Markel Group’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Markel Group Fairly Valued? Valuation Analysis

Q8-A1. Markel Group’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Markel Group vs Peers: Valuation Comparison

Q8-A3. Is Markel Group Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Markel Group? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. Markel Group’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Markel Group? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Markel Group?

Q9-A2. How Sensitive Is Markel Group to the Economy?

Q9-A3. Markel Group Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Markel Group Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Markel Group? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Markel Group’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Markel Group’s Equity Portfolio Volatility Its Biggest Weakness?

Q2: Can Markel Group’s 14x P/E Be Justified Given the Sub-Peer Insurance Returns Highlighted by Activist Investors?

Q3: How Will the Exit from Global Reinsurance and Hagerty Fronting Model Transition Impact Future Underwriting Margins?

Q4: Does Markel Ventures Provide a True Moat, or Is It a Drag on Valuation as JANA Partners Suggests?

Q5: How Does the Continued Pace of Share Repurchases Support the Long-Term Intrinsic Value Compounding?

Q6: Can the Fixed-Income Portfolio Sustain Its Current High Yield Environment?

Q7: Are the Recent Macroeconomic Headwinds and Inflation Directly Threatening the Growth of the Industrial Segment?

Q8: What Role Do Alternative and Specialty Insurance Lines Play in Insulating Markel Group from Standard P&C Pricing Cycles?

Q9: Can the Recent “Markel Style” Cultural Continuity Survive the Broader Strategic Shifts Demanded by Wall Street?

Q10: Does Markel Group’s Heavy Cash Position Truly Provide a Safety Margin Against a Severe US Equity Market Drawdown?

Markel Group Inc. (MKL)